Trends In Orphan Drug Spending And Out-Of-Pocket Spending Among US Children, 2013

Trends In Orphan Drug Spending And Out-Of-Pocket Spending Among US Children, 2013–18

Published:2020-10-01 Issue:10 Volume:39 Page:1806-1811
ISSN:0278-2715
Container-title:Health Affairs
language:en
Short-container-title:Health Affairs

Author:

Chua Kao-Ping¹,Conti Rena M.²

Affiliation:

1. Kao-Ping Chua () is an assistant professor in the Department of Pediatrics and the Susan B. Meister Child Health Evaluation and Research Center at the University of Michigan Medical School, in Ann Arbor, Michigan.

2. Rena M. Conti is an associate professor in the Department of Markets, Public Policy, and Law at the Questrom Boston University School of Business, in Boston, Massachusetts.

Publisher

Health Affairs (Project Hope)

Subject

Health Policy

Reference4 articles.

1. Pediatric Orphan Drug Indications: 2010–2018

2. Nusinersen for Spinal Muscular Atrophy

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative policy analysis of national rare disease funding policies in Australia, Singapore, South Korea, the United Kingdom and the United States: a scoping review;Health Economics Review;2024-06-19

2. Principles of Child Health Care Financing;Pediatrics;2023-08-28

3. Disentangling the Cost of Orphan Drugs Marketed in the United States;Healthcare;2023-02-13

4. Trends in orphan drug use and spending among children and adolescents during 2010–2020 in Korea;Frontiers in Pharmacology;2022-08-31

5. The economics of moonshots: Value in rare disease drug development;Clinical and Translational Science;2022-03-25